Skip to main content
Respiration FailureLungs and breathing

What this study is

Cardiac disease complicated by respiratory insufficiency comprises the most frequent indication for cardiac intensive care unit (CICU) admission, with nearly one-third patients requiring advanced respiratory support and over 20% patients requiring invasive mechanical ventilation (IMV). IMV among patients with impaired cardiovascular reserve is further compounded by the adverse impact of positive pressure ventilation (PPV) and systemic sedation on intracardiac hemodynamics, pulmonary vascular mechanics and consequently end-organ perfusion. Despite widespread use, evidence guiding optimal ventilatory practices and mode selection in cardiovascular intensive care unit patients remains limited. Pressure-controlled and volume-controlled ventilation may differ in their effects on patient-ventilator synchrony, sedation requirements, and hemodynamic impact, but comparative data among patients with critical cardiac disease remains inconclusive. This pilot study will evaluate the feasibility of implementing a pragmatic cluster-randomized crossover trial comparing ventilatory modes in a contemporary cardiovascular intensive care unit.

What's being tested

  • Volume Controlled Mode

    Intervention · OTHER

    Volume-controlled mode for continuous mandatory ventilation with preset inspiratory flow and tidal volume.

  • Pressure Controlled Mode

    Intervention · OTHER

    Pressure-controlled mode for continuous mandatory ventilation with preset inspiratory pressure above positive end-expiratory pressure.

Study details

Official title
COMPARE-VENT Feasibility Pilot Study: A Pragmatic Cluster Randomized Crossover Trial for Ventilation Strategies and Hemodynamic Impact in Critically Ill Patients With Cardiovascular Disease
Sponsor
Mayo Clinic
Conditions
Respiration Failure · Cardio Vascular Disease · Cardiogenic Pulmonary Oedema · Critical Illness · Mechanical Ventilation · Cardiogenic Shock · Cardiopulmonary
Enrolling
75 people
Starts
2026-07-01
Est. completion
2027-06-30
Design
Open-label, randomized, crossover
Record
View on ClinicalTrials.gov ↗